drugset / Trial / NCT01344148
Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine the best time to begin anti-HIV(Acquired Immunodeficiency Syndrome) treatment in individuals who co-infected with HIV and tuberculosis (Tb). This prospective, randomized study is being conducted on HIV/Tb co-infected patients in China to evaluate and compare the efficacy of antiretroviral therapy after 2 weeks TB treatment versus deferred ART initiated 8 weeks after initiation of TB treatment.
Timeline
- Start
- 2009-02
- Primary completion
- 2011-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | — | — |
| Subject | Lamivudine | Other / unclassified | — | — |
| Subject | Stavudine | Other / unclassified | — | — |
| Subject | Zidovudine | Small molecule | — | — |
| Background | Ethambutol | Small molecule | — | — |
| Background | Isoniazid | Small molecule | — | — |
| Background | Pyrazinamide | Small molecule | — | — |
| Background | Rifabutin | Small molecule | — | — |
| Background | Rifampin | Small molecule | — | — |